IP Library Granted Patent US 10,441,575
Granted Patent B2
US 10,441,575 · App. 15/914,804 · Granted Oct 15, 2019

Drug compositions

Inventors: David Clayton Sutherland (Little Rock, AR); James Kyle Zorn (Lexington, KY); Dennis J. Carlo (San Diego, CA)
Assignee: Adamis Pharmaceuticals Corporation
A61K31/4184A61K9/10A61K9/145A61K9/1641A61K9/1652A61K31/4439A61K45/06A61K47/38A61K2300/00C01D5/14C01D7/10C08B3/06C08L1/286
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,441,575
App. No.
15/914,804
Granted
Oct 15, 2019
Kind
B2
Abstract

Described herein are pharmaceutical compositions including a proton pump inhibitor and an antiparasitic drug. In some embodiments, the compositions can be formulated as a non-solid for oral administration. The compositions can be used to treat gastrointestinal conditions. Methods of treatment using the compositions are also described.

Claims (17)

1. A method of treating a gastrointestinal ulcer, the method comprising:

administering an oral paste including about 22% w/v omeprazole, about 30% w/v fenbendazole, and a wetting agent formulated in a melted polyethylene glycol base agent to a mammal having the gastrointestinal ulcer, and

treating the gastrointestinal ulcer.

2. The method of claim 1 , wherein the administration is performed using an oral syringe.

3. The method of claim 1 , wherein the mammal is a human, a horse, or a camel.

4. The method of claim 1 , wherein the gastrointestinal ulcer is greater than Grade 1.

5. The method of claim 1 , wherein the treating is clinical healing resulting in an ulcer score less than 1.

6. The method of claim 1 , wherein the treating is clinical healing resulting in an ulcer score of 0.

7. The method of claim 1 , wherein the treating is in less than about 30 days.

8. The method of claim 1 , wherein the treating is in less than about 14 days.

9. The method of claim 1 , wherein the administering is once daily.

10. The method of claim 1 , wherein the administering is twice daily.

11. The method of claim 1 , wherein the wetting agent is a polyethylene glycol.

12. The method of claim 1 , wherein the oral paste further includes sodium sulfite.

13. The method of claim 1 , wherein the oral paste further includes carboxymethyl cellulose.

14. The method of claim 1 , wherein the oral paste further includes sodium bicarbonate.

15. The method of claim 1 , wherein the oral paste further includes a flavoring agent.

Assignments (5)
SECURITY INTEREST Recorded May 13, 2026
From: FARMAKEIO OUTSOURCING LLC; FARMAKEIO AR LLC
To: FIRST-CITIZENS BANK & TRUST COMPANY, AS ADMINISTRATIVE AGENT
Reel/Frame 074646/0453 →
NUNC PRO TUNC ASSIGNMENT Recorded Oct 11, 2023
From: ADAMIS PHARMACEUTICALS CORPORATION
To: FARMAKEIO AR LLC
Reel/Frame 065183/0622 →
CHANGE OF NAME Recorded Sep 28, 2023
From: ADAMIS PHARMACEUTICALS CORPORATION
To: DMK PHARMACEUTICALS CORPORATION
Reel/Frame 065082/0445 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 7, 2018
From: SUTHERLAND, DAVID CLAYTON; ZORN, JAMES KYLE
To: ADAMIS PHARMACEUTICALS CORPORATION
Reel/Frame 045137/0591 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 7, 2018
From: CARLO, DENNIS J.
To: ADAMIS PHARMACEUTICALS CORPORATION
Reel/Frame 045137/0671 →
Continuity (3)
Division 15675435 · Aug 11, 2017
Provisional Application 62373871 · Aug 11, 2016
Related Publication 20180193316A1 · Jul 12, 2018